← All organizations

OBI Pharma, Inc

For profitWebsite ↗

Also known as: AP Biosciences Inc. | OBI Pharma, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 20, 2025

Timeline

2000s

Jun 1, 2002
OBI Pharma, Inc— Founded

Drugs by trial phase (14 distinct, 14 trials)

Phase 3 (1 own, 0 via acquisition)

adagloxad simolenin

Phase 2 (9 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT07165067Lead sponsorPhase 1Sep 20, 2025
NCT07124117Lead sponsorPhase 1/Phase 2Aug 4, 2025
NCT06669975Lead sponsorPhase 1/Phase 2Dec 1, 2024
NCT06480240Lead sponsorPhase 1/Phase 2Jun 12, 2024
NCT06723964Lead sponsorPhase 1Mar 30, 2023
NCT05473156Lead sponsorPhase 1/Phase 2Dec 31, 2022
NCT05442060Study directorPhase 2Jul 27, 2022
NCT05442060Lead sponsorPhase 2Jul 27, 2022
NCT04084366Lead sponsorPhase 1/Phase 2Jan 15, 2020
NCT03562637Study chairPhase 3Oct 19, 2018
NCT03562637Lead sponsorPhase 3Oct 19, 2018
NCT03592264Lead sponsorPhase 1/Phase 2Jun 7, 2018
NCT03573544Lead sponsorPhase 1May 7, 2018
NCT02310464Lead sponsorPhase 1Dec 1, 2015
NCT02132988CollaboratorPhase 2Nov 1, 2013

Details

Founded: Taipei, TW Jun 1, 2002
Last known activity: Sep 20, 2025